SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001493152-24-004951
Filing Date
2024-02-05
Accepted
2024-02-05 17:00:28
Documents
18

Document Format Files

Seq Description Document Type Size
1 form424b4.htm 424B4 3124449
2 form424b4_001.jpg GRAPHIC 8919
3 form424b4_002.jpg GRAPHIC 47839
4 form424b4_003.jpg GRAPHIC 30464
5 form424b4_004.jpg GRAPHIC 61385
6 form424b4_005.jpg GRAPHIC 54626
7 form424b4_006.jpg GRAPHIC 42869
8 form424b4_007.jpg GRAPHIC 32974
9 form424b4_008.jpg GRAPHIC 38440
10 form424b4_009.jpg GRAPHIC 20847
11 form424b4_010.jpg GRAPHIC 24101
12 form424b4_011.jpg GRAPHIC 31739
13 form424b4_012.jpg GRAPHIC 60287
14 form424b4_013.jpg GRAPHIC 139660
15 form424b4_014.jpg GRAPHIC 38962
16 form424b4_015.jpg GRAPHIC 49742
17 form424b4_016.jpg GRAPHIC 8919
18 form424b4_017.jpg GRAPHIC 30037
  Complete submission text file 0001493152-24-004951.txt   4121400
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-276502 | Film No.: 24596594
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)